"There seems there's no impact to reputation here."
Really? I'd suggest the market thinks otherwise..
Of course JH is going to give the perception that everything is all rosy, but the fact that this oversight occurred implies a degree of carelessness by the company..
In saying that, my opinion is that the sp will gradually make its way up again closer to approval date as prices become 'tempting'.
DYOR
Ann: QRxPharma Updates MOXDUO NDA Review , page-9
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)